Products & deployments

  • Lifeyear Secures €2.8M to Accelerate Digital Cardiovascular Care in the UK

    Lifeyear, a UK-Estonian healthtech start-up, has raised €2.8 million to launch its remote patient management platform to deliver at-home digital cardiovascular care. With cardiovascular disease (CVD) projected to surge in prevalence and with UK cardiac waiting lists exceeding 418,000 people, the funding marks Lifeyear’s timely entry into the UK market, positioning it to lead the [...]

  • Doctors stop using bedside ultrasound despite training

    Many doctors stop using point-of-care ultrasound (POCUS) shortly after training due to workplace barriers that prevent it from becoming routine, new research suggests. POCUS devices allow rapid bedside imaging and can identify conditions such as heart failure, fluid in the lungs, and internal bleeding — all of which may be treatable if caught early. Although [...]

  • MHRA opens second round of AI testing scheme

    The MHRA has opened applications for the second round of its AI Airlock programme, backed by £1m to expand regulatory testing of AI-powered medical devices. The scheme allows companies to work with regulators in a controlled ‘sandbox’ environment, where AI-driven health technologies can be safely tested and refined before wider rollout. Applications opened on 23 [...]

  • GPs begin prescribing Mounjaro weight-loss jabs in England

    GP surgeries in England start prescribing Mounjaro today, but only patients with severe obesity and multiple health conditions will qualify under strict eligibility rules. The weekly injection, which helps suppress appetite to support weight loss of up to 20 per cent of body weight, is being rolled out in phases by NHS England. The approach [...]

  • SandboxAQ releases AI dataset for drug discovery

    Artificial intelligence firm SandboxAQ has released a dataset designed to help researchers predict drug-protein binding, a key step in early drug development. The company generated approximately 5.2 million synthetic 3D molecules using Nvidia chips, instead of through traditional laboratory experiments. The dataset, released on Wednesday, is intended to support the development of faster drug screening [...]

  • PointCaré raises €1.5m for ICU data platform

    Ghent-based startup PointCaré has raised nearly €1.5m from private investors to develop a platform that interprets real-time data in intensive care units (ICUs) and operating rooms. The company is developing OnTarget, a system that analyses data streams from various medical devices and provides tailored clinical advice based on the patient and the clinical situation. PointCaré [...]

  • Naitive announces publication of study demonstrating diagnostic accuracy of osteoSight

    Musculoskeletal med tech company Naitive Technologies has published results demonstrating the diagnostic performance of its AI-powered tool, OsteoSight, for identifying people at risk of low bone mineral density (BMD). The results, published in Osteoporosis International, validate the utility of OsteoSight in detecting low BMD using routine X-rays that have been taken for other purposes. Robert [...]

  • Phoenix Hospital Group launches rapid-access Memory Clinic in Harley Street

    Phoenix Hospital Group has launched a new Same Day Memory Clinic within the Harley Street Health District, offering a full cognitive assessment and diagnosis within days. As part of its growing portfolio of health assessments and preventative health screens, this new consultant-led service expands Phoenix Hospital Group's offering. It provides same-day access to memory specialists, [...]

  • McDermott advises GPP on acquiring a majority stake in Eutecma

    McDermott Will & Emery advised Great Point Partners (“GPP”), a Greenwich-based private investment firm focused on the healthcare industry, on the acquisition of a majority stake in Eutecma, a German-based developer of packaging solutions for pharmaceutical cold chain shipments. With this partnership, Eutecma has also acquired Resolvision, Eutecma’s proprietary re-use machine technology utilized at its [...]

  • Artificial pancreas reaches 20,000 children in England

    Around 20,000 children and young people with type 1 diabetes in England are now using so-called 'artificial pancreas' systems following recommendations from NICE. Hybrid closed loop (HCL) systems—made up of an insulin pump, continuous glucose monitor and algorithm—automate insulin delivery and adjust doses in real time based on blood sugar levels. The technology has reached [...]